We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic def... WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Show more
Statistically significant, potent, and durable allele-selective silencing: 46% mean reduction in CSF mutant huntingtin (mHTT) protein compared to placebo, preservation of wild-type huntingtin...
Presentation at the Obesity & Weight Loss Drug Development Summit to review Real World Evidence for the GLP-1 class and the opportunity for Wave’s INHBE program as a best-in-class approach for...
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...
RestorAATion-2 clinical trial of WVE-006 in AATD patients underway; expected proof-of-mechanism data in patients with AATD remains on track for 2024 INHBE program for obesity expected clinical...
CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...
CAMBRIDGE, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.75 | 12.9757785467 | 5.78 | 6.56 | 5.73 | 813345 | 6.16084822 | CS |
| 4 | 1.59 | 32.1862348178 | 4.94 | 6.56 | 4.87 | 692957 | 5.81075181 | CS |
| 12 | 0.6 | 10.1180438449 | 5.93 | 6.63 | 4.25 | 858379 | 5.54746679 | CS |
| 26 | 2.13 | 48.4090909091 | 4.4 | 7.67 | 3.5 | 871408 | 5.49445023 | CS |
| 52 | 2.62 | 67.0076726343 | 3.91 | 7.67 | 3.5 | 670906 | 5.32996538 | CS |
| 156 | 0.73 | 12.5862068966 | 5.8 | 7.67 | 1.16 | 529013 | 4.52050291 | CS |
| 260 | -13.71 | -67.7371541502 | 20.24 | 39.99 | 1.16 | 593721 | 7.17504579 | CS |
Monksdream
3 weeks ago
PonkenPlonken
4 weeks ago
Monksdream
3 months ago
Monksdream
5 months ago
TrendTrade2016
5 months ago
TrendTrade2016
5 months ago
PRIVATE SHAREHOLDER
2 years ago
PRIVATE SHAREHOLDER
2 years ago
MiamiGent
2 years ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
